Daniel Zamfir

Allucent

Daniel brings more than 24 years of experience in clinical drug development, operations, program and business strategy, and relationship and account management, including recent experience in CRO executive leadership roles. His background includes 14 years in oncology and several years working in cell, gene, and RNA therapies.

Throughout his career, Daniel has helped clients develop go-to-clinic strategies, select CRO partners, manage projects and programs, and navigate the operational challenges of conducting global clinical trials across a variety of therapeutic areas.